Today: 27 June 2026
Analog Devices stock rises after UBS boosts ADI target to $400 — earnings next
9 February 2026
1 min read

Analog Devices stock rises after UBS boosts ADI target to $400 — earnings next

New York, February 9, 2026, 12:41 EST — Regular session

  • ADI picked up around 0.7% by midday after UBS bumped its price target to $400
  • The company released a shareholder slide deck, pushing investors to reject proposals for relaxed special-meeting rules.
  • Attention shifts to Feb. 18 earnings, with investors hunting for clues on industrial appetite and what’s ahead for autos.

Analog Devices (ADI.O) shares edged up 0.7% to $322.74 by midday in New York, following a Friday close at $320.45. UBS earlier bumped its price target on the chipmaker to $400, fueling the move.

This call is in focus as investors look for signs the analog chip cycle might be shifting. ADI’s semiconductors show up in factory machinery, autos, and data-center gear—demand here tends to move fast, especially when clients start burning off excess stock.

Earnings are just around the corner, and that timing could prove critical. Broker notes have been the main crutch for traders pushing valuations higher. The real test, though, comes with the next management update—whether the rally keeps going probably hinges on what they say.

UBS stuck with its buy rating and boosted the price target to $400, up from $320, according to Investing.com. The firm also bumped up its earnings-per-share estimates for fiscal 2026 and 2027, now at $10.86 and $13.78. UBS cited robust demand in data centres, aerospace and defense, plus test and instrumentation sectors. It now values the company at a 28 times comparable-company multiple, previously 25 times.

Brokers set price targets to guess where a stock might land in the next year. When those targets get a bump, investors usually take that as a green light to buy—at least until fresh results shake things up.

Analog Devices filed a shareholder presentation with the U.S. SEC on Monday, pushing back against a proposal to relax requirements for calling a special meeting. The company argued its current bylaws already let investors owning at least 25% of shares for a year call these meetings, and cautioned that doing so can be “costly and distracting.” archive.fast-edgar.com

The debate comes as chipmakers tied to industrial markets push to convince investors there’s a recovery brewing outside of smartphones. Texas Instruments and NXP Semiconductors—key analog names—are often the yardsticks for tracking demand shifts.

Still, the move up in the stock isn’t dramatic—and it wouldn’t take much to flip the script. For analog suppliers, autos are notoriously volatile, and with shares hovering close to recent highs, even a slight miss on guidance could spark sharper losses.

Analog Devices is set to report fiscal first-quarter results on Feb. 18. Investors will be zeroed in on comments about industrial orders, automotive demand, and any signs of momentum tied to data centers.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Snowflake Shares Surge 9.65% on Russell Rebalance, Ends Week Up 7.2%
    June 27, 2026, 11:40 AM EDT. Snowflake Inc (NYSE:SNOW) shares jumped 9.65% on Friday to $248.96, reversing a midweek dip and closing the week up 7.2% from June 18. The surge was driven by heavy trading volumes of 25.61 million shares amid FTSE Russell's U.S. index rebalance, injecting roughly $150 billion in market liquidity. The stock faces a key test next week as the rebalance impacts settle. Snowflake's recent strong earnings report showed first-quarter fiscal 2027 product revenue up 34% to $1.33 billion and boosted full-year revenue guidance to $5.84 billion. CEO Sridhar Ramaswamy highlighted AI as a growth driver, while a $6 billion AWS deal supports the company's expansion outlook.

Latest articles

PayPal stock surge shifts short-interest story into next week

PayPal stock surge shifts short-interest story into next week

27 June 2026
PayPal surged 4.5% to $44.29 Friday on trading volume more than double its 65-day average, following a 9.7% jump in short interest to 54.35 million shares as of June 15, equal to 6.2% of float; despite the rally, shares remain 44% below last year’s high, with the stock still seen as a turnaround play and a shortened trading week ahead due to the July 3 U.S. holiday.
Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

27 June 2026
Uber surged 5.47% to $76.20 on Friday with trading volume 3.46 times its 65-day average, as investors weighed tighter U.S. driver background checks set to remove tens of thousands of gig workers starting Monday—raising potential impacts on trips, wait times, and margins while the stock remains 25.3% below its 52-week high.
Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

27 June 2026
Honeywell’s two-for-one split launches Monday, giving investors one Honeywell Technologies share and one Honeywell Aerospace (HONA) share for every two old shares, with the combined package valued at $464.42 at Friday’s close; both stocks debut as separate S&P 500 members, while HONA joins the S&P 100, setting up a pivotal test for holders as the market reopens.
Generate Biomedicines stock ends week back above IPO price as volume jumps

Generate Biomedicines stock ends week back above IPO price as volume jumps

27 June 2026
Generate Biomedicines (NASDAQ:GENB) surged 13.7% since June 18 to close Friday at $16.47—above its $16 IPO price—with heavy volume and a $2.11B market cap, as investors weigh its $516.6M cash pile, ongoing clinical trial risks, and lack of product revenue, while sector momentum lifts biotech stocks.
US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data
Previous Story

US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Next Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Go toTop